ZIM Laboratories Limited (ZIMLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
556
First IPO Date
November 25, 2022
| Name | Title | Pay | Year Born |
| Prakash Pralhadrao Sapkal | Head of ODS Business, Formulations of Domestic, ROW & Emerging Markets & Director | 8.51M | 1968 |
| Niraj Pukhraj Dhadiwal | Director of Business Development & Executive Director | 9.58M | 1967 |
| Zulfiquar Murtaza Kamal | Director of Finance & Executive Director | 10.19M | 1961 |
| Anwar Siraj Daud | Executive Chairman & MD | 15.41M | N/A |
| Jitendra Kumar Pandey | Vice President of Human Resource | 0 | N/A |
| Piyush Siddheshwar Nikhade | Company Secretary & Compliance Officer | 0 | N/A |
| Shyam Mohan Patro | Chief Financial Officer | 0 | N/A |
| Vijay Fudke | Senior Vice President of Technical Services | 0 | N/A |
| Vikrant Bendre | President of International Business | 0 | 1978 |
| Zain Daud | Investor Relations Officer | 0 | N/A |
Established in 1984 and based in Nagpur, India, ZIM Laboratories Limited is a pharmaceutical company that develops, produces, and supplies both finished drug formulations and pre-formulation ingredients. Operating domestically and internationally, ZIM specializes in providing technology-driven drug delivery solutions and exclusive, non-infringing manufacturing processes for generic pharmaceuticals. These offerings span semi-finished and finished product categories, encompassing forms like granules, pellets, taste-masked powders, suspensions, tablets, capsules, and oral thin films. Their extensive product range caters to various therapeutic areas, including urology, gastroenterology, cardiology, and anticoagulation, alongside antibiotics, anti-infectives, NSAIDs/pain management, and vitamins and supplements.